Immuno-oncology Archives - Oncology Central Oncology Central

i
i

10 Dec 2019 Hematologic
Prior treatment with PD-1 improves safety of stem cell transplants in Hodgkin lymphoma
25 Nov 2019 Head and neck
Pembrolizumab approved as standard first-line therapy for head and neck cancer
7 Oct 2019 Opinion
Comprehensive genomic profiling: driving a new standard of cancer care
29 Sep 2019 Gynecologic
ESMO 2019 day 1 highlights: CheckMate-227 and CheckMate 067 trial results
24 Sep 2019 Spotlight on immuno-oncology
Spotlight survey on immuno-oncology
18 Sep 2019 Lung
Response to anti-PD-1 immunotherapy in lung cancer could be determined by eNose
19 Jun 2019 Immuno-oncology
How do gut microorganisms influence the immune system and cancer treatment?
2 Jun 2019 Breast
ASCO19: ribociclib combined with endocrine therapy increases survival in breast cancer patients
1 Jun 2019 Lung
ASCO19: 5-year data shows that pembrolizumab increases survival rates for certain NSCLC patients
2 May 2019 Journal Articles
Talimogene laherparepvec: review of its mechanism of action and clinical efficacy and safety
24 Apr 2019 Gastrointestinal
At the crossroads: the intersection of the gut microbiome and immuno-oncology
24 Apr 2019 Renal
Keytruda® in combination with Inlyta® receives US FDA approval for renal cell carcinoma